sigma plot windows version 11.0 (WPCubed GmbH)
90
Structured Review
WPCubed GmbH
sigma plot windows version 11.0
Sigma Plot Windows Version 11.0, supplied by WPCubed GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigma+plot+version+12/sigma+plot+windows+version+11+0/pm26006330-70-39-42
Average 90 stars, based on 1 article reviews
Sigma Plot Windows Version 11.0, supplied by WPCubed GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigma+plot+version+12/sigma+plot+windows+version+11+0/pm26006330-70-39-42
Average 90 stars, based on 1 article reviews
sigma plot windows version 11.0 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
In Vitro:Article Title: Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer. Article Snippet: The determination coefficient (R2) and sum of squares of residuals (SSR) were used as the indicators of the best fit to release data for each model. All model parameters of drugs release profiles were computed using Sigma Plot for Article Title: Sublingual delivery of chondroitin sulfate conjugated tapentadol loaded nanovesicles for the treatment of osteoarthritis. Article Snippet: Recent treatment approaches of osteoarthritis (OA) face a number of obstacles due to the progressive multitude of pain generators, nociceptive mechanisms, first pass mechanism, less efficacy and compromised safety.. The present study was aimed to bring a novel approach for the effective management of OA, by developing sublingual targeted nanovesicles (NVs) bearing tapentadol HCl (TAP), surface modified with chondroitin sulphate (CS).. Optimised nontargeted nanovesicle formulation (MB-NV) was developed by an ultrasound method, characterised as spherical in shape , nanometric in size (around 150 nm) with narrow size distribution (polydispersity index <0.5), and good entrapment efficiency (around 50 %). Article Title: Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer. Article Snippet: In vitro drugs release kinetics model fitting and Kaplan–Meier survival analysis were carried out using Sigma Plot for Article Title: Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis. Article Snippet: Purpose The debut study was aimed to develop Lactic acid (LA)conjugated solid lipid nanoparticles (SLN-LA) bearing albendazole (ALB) and prednisolone (PRD) for effective management of neurocysticercosis (NCC).. Methods LA was coupled to SLN by post-insertion technique.. SLNs were characterized for particle size and size distribution, shape, and percent drug entrapment efficiency. Software:Article Title: Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer. Article Snippet: The determination coefficient (R2) and sum of squares of residuals (SSR) were used as the indicators of the best fit to release data for each model. All model parameters of drugs release profiles were computed using Sigma Plot for Article Title: Sublingual delivery of chondroitin sulfate conjugated tapentadol loaded nanovesicles for the treatment of osteoarthritis. Article Snippet: Recent treatment approaches of osteoarthritis (OA) face a number of obstacles due to the progressive multitude of pain generators, nociceptive mechanisms, first pass mechanism, less efficacy and compromised safety.. The present study was aimed to bring a novel approach for the effective management of OA, by developing sublingual targeted nanovesicles (NVs) bearing tapentadol HCl (TAP), surface modified with chondroitin sulphate (CS).. Optimised nontargeted nanovesicle formulation (MB-NV) was developed by an ultrasound method, characterised as spherical in shape , nanometric in size (around 150 nm) with narrow size distribution (polydispersity index <0.5), and good entrapment efficiency (around 50 %). Article Title: Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer. Article Snippet: In vitro drugs release kinetics model fitting and Kaplan–Meier survival analysis were carried out using Sigma Plot for Article Title: Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis. Article Snippet: Purpose The debut study was aimed to develop Lactic acid (LA)conjugated solid lipid nanoparticles (SLN-LA) bearing albendazole (ALB) and prednisolone (PRD) for effective management of neurocysticercosis (NCC).. Methods LA was coupled to SLN by post-insertion technique.. SLNs were characterized for particle size and size distribution, shape, and percent drug entrapment efficiency. |